14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
ZGM vs SBC: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, SBC Medical Group Holdings Incorporated (SBC) captures the overall head-to-head institutional edge over Zenta Group Company Limited (ZGM) on higher Unified Composite conviction (47.2/100 HOLD vs. 59.4/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples, Growth & Scale), while ZGM wins 3–2 across the 6-pillar growth and valuation breakdown. ZGM trades at $1.65 (N/M Forward P/E, 31.7% operating margin) versus SBC at $5.17 (9.0x Forward P/E, 39.9% operating margin).
Composite vs. Pillar Nuance: While ZGM currently prints a higher short-term Unified Composite Score (59.4/100 HOLD vs. SBC 47.2/100 HOLD), SBC captures the overall institutional head-to-head verdict (7–3 matrix metrics and 2–3 across the 6 pillars) due to superior fundamental profitability (39.9% vs. 31.7% operating margin) and revenue trajectory (+35.1% vs. -27.0% YoY).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ZGM vs SBC. Trailing 12-month operating profitability (ZGM 31.7% vs SBC 39.9%) and valuation multiples (ZGM N/M vs SBC 9.0x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Consulting Services value chain with $18.2M market capitalization and 31.7% operating margin.
OpEx & R&D Reinvestment46.4% of Rev ($1.5M)
90D Engineering Disclosures0 Published
SBC Moat ProfileHigh-Margin Pricing Power Moat
Consulting Services Operator
Competes within the Consulting Services value chain with $574.4M market capitalization and 39.9% operating margin.
OpEx & R&D Reinvestment32.3% of Rev ($61M)
90D Engineering Disclosures0 Published
Investor FAQ ZGM vs SBC Key Questions & Quantitative Answers
As of Nov 20, 2026, SBC Medical Group Holdings Incorporated (SBC) captures the overall head-to-head institutional edge over Zenta Group Company Limited (ZGM) on higher Unified Composite conviction (47.2/100 HOLD vs. 59.4/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples, Growth & Scale), while ZGM wins 3–2 across the 6-pillar growth and valuation breakdown. ZGM trades at $1.65 (N/M Forward P/E, 31.7% operating margin) versus SBC at $5.17 (9.0x Forward P/E, 39.9% operating margin). Composite vs. Pillar Nuance: While ZGM currently prints a higher short-term Unified Composite Score (59.4/100 HOLD vs. SBC 47.2/100 HOLD), SBC captures the overall institutional head-to-head verdict (7–3 matrix metrics and 2–3 across the 6 pillars) due to superior fundamental profitability (39.9% vs. 31.7% operating margin) and revenue trajectory (+35.1% vs. -27.0% YoY).
SBC leads the Growth & Scale pillar: ZGM posts -27.0% YoY revenue growth and -78.0% YoY earnings growth on $3.2M TTM revenue (78.1% gross margin, 31.7% operating margin), compared with SBC at +35.1% YoY revenue growth and +22.4% YoY earnings growth on $190M TTM revenue (72.2% gross margin, 39.9% operating margin). On trailing 12-month operating scale, ZGM generates $3.2M in USD-normalized revenue versus $190M for SBC. In operating R&D and SG&A reinvestment, ZGM deploys 46.4% of Rev ($1.5M) (0 90-day corporate R&D disclosures) versus 32.3% of Rev ($61M) (0 disclosures) for SBC.
SBC screens cheaper on headline valuation multiples. ZGM trades at N/M Forward P/E, 15.4x Trailing P/E, N/M PEG, and 5.7x EV/Revenue (42.7% EBITDA margin), whereas SBC trades at 9.0x Forward P/E, 11.0x Trailing P/E, 2.40x PEG, and 3.0x EV/Revenue (41.8% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ZGM (23.4% ROE) versus SBC (19.3% ROE) capital efficiency.
In options market volatility and institutional positioning, ZGM carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.88β · 161% Vol realized risk). By comparison, SBC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.96β · 159% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.